Key result
Elevated EASIX score linked to ~162% greater CIN risk after TAVR.
Why the study?
Contrast-induced nephropathy remains a major determinant of morbidity and mortality after TAVR, but the prognostic value of the endothelial-damage score EASIX had never been explored in this setting.
Does the EASIX score predict contrast-induced nephropathy in patients undergoing TAVR?
Does the EASIX score predict contrast-induced nephropathy in patients undergoing TAVR?
The EASIX score, calculated from routine laboratory values, is a strong and independent predictor of contrast-induced nephropathy after TAVR, enabling simple pre-procedural risk stratification.
Supports pre-TAVR CIN risk stratification with routine labs; extends EASIX utility and warrants prospective validation.
Transcatheter aortic valve replacement (TAVR) is being performed in increasingly complex, high-risk cohorts, and contrast-induced nephropathy (CIN) remains a major determinant of morbidity and mortality. The endothelial-damage score EASIX (lactate dehydrogenase × creatinine/platelet count) is a validated prognostic index in hematology and critical care but has never been explored after TAVR. We retrospectively analyzed 130 consecutive severe AC patients (mean age 76.8 ± 8.4 years; 47.8% male) who underwent transfemoral TAVR (February 2019-March 2021). CIN was defined as a ≥25% or ≥0.5 mg/dL creatinine rise within 72 hours. The predictive value of EASIX was assessed with receiver operating characteristic analysis and multivariable logistic regression. CIN occurred in 15.4% (n = 20). Baseline EASIX was higher in CIN+ vs CIN- (2.92 ± 1.28 vs 1.33 ± 1.30; P < .001). An EASIX threshold ≥ 1.904 predicted CIN with 90.3% sensitivity and 86.2% specificity (area under the curve 0.91; P < .001). In multivariable analysis, EASIX (OR 2.62; P = .023), contrast volume, and baseline eGFR independently predicted CIN. EASIX, obtainable from routine laboratories, is an independent, high-performance predictor of CIN after TAVR and may facilitate pre-procedural risk stratification.
No takes yet. Share an insight, caveat, or question.
Özen et al. (2026) studied this question. An EASIX score ≥1.904 predicted contrast-induced nephropathy after TAVR with 90.3% sensitivity and 86.2% specificity, independently increasing CIN risk (OR 2.62).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: